Home/Filings/4/0001439222-22-000005
4//SEC Filing

Car Bruce 4

Accession 0001439222-22-000005

CIK 0001439222other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 4:07 PM ET

Size

8.3 KB

Accession

0001439222-22-000005

Insider Transaction Report

Form 4
Period: 2022-02-10
Car Bruce
Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Common stock

    2022-02-10+3,66712,992 total
  • Tax Payment

    Common stock

    2022-02-10$31.43/sh1,073$33,71911,919 total
  • Exercise/Conversion

    Restricted stock units

    2022-02-103,6677,333 total
    Common stock (3,667 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
  • [F2]The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments.

Issuer

AGIOS PHARMACEUTICALS, INC.

CIK 0001439222

Entity typeother

Related Parties

1
  • filerCIK 0001798876

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:07 PM ET
Size
8.3 KB